Schizophrenia Treatment Landscape: Are Second-Generation Antipsychotics Still King? Schizophrenia is a chronic and severe mental illness affecting millions globally. While there's no cure, second-generation antipsychotics (SGAs) have become the mainstay of treatment. But as an investor in the Schizophrenia Market, you likely have questions: Do Second-Generation Antipsychotics Still...